GB1583625A - Compositions for pharmacologically treating drug addiction and schizophrenia - Google Patents

Compositions for pharmacologically treating drug addiction and schizophrenia Download PDF

Info

Publication number
GB1583625A
GB1583625A GB1969978A GB1969978A GB1583625A GB 1583625 A GB1583625 A GB 1583625A GB 1969978 A GB1969978 A GB 1969978A GB 1969978 A GB1969978 A GB 1969978A GB 1583625 A GB1583625 A GB 1583625A
Authority
GB
United Kingdom
Prior art keywords
methyl
alpha
ampt
composition
tyrosine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB1969978A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
POZUELO J
Original Assignee
POZUELO J
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US05/797,372 external-priority patent/US4117161A/en
Priority claimed from US05/842,665 external-priority patent/US4165382A/en
Application filed by POZUELO J filed Critical POZUELO J
Publication of GB1583625A publication Critical patent/GB1583625A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GB1969978A 1977-05-16 1978-05-16 Compositions for pharmacologically treating drug addiction and schizophrenia Expired GB1583625A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US05/797,372 US4117161A (en) 1977-05-16 1977-05-16 Method of pharmacologically treating drug addiction with alpha-methyl-para-tyrosine
US05/842,665 US4165382A (en) 1977-10-17 1977-10-17 Method of pharmacologically treating schizophrenia with alpha-methyl-para-tyrosine

Publications (1)

Publication Number Publication Date
GB1583625A true GB1583625A (en) 1981-01-28

Family

ID=27121870

Family Applications (1)

Application Number Title Priority Date Filing Date
GB1969978A Expired GB1583625A (en) 1977-05-16 1978-05-16 Compositions for pharmacologically treating drug addiction and schizophrenia

Country Status (3)

Country Link
DE (1) DE2821236A1 (US20080094685A1-20080424-C00004.png)
FR (1) FR2390955A1 (US20080094685A1-20080424-C00004.png)
GB (1) GB1583625A (US20080094685A1-20080424-C00004.png)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3362879A (en) * 1965-01-11 1968-01-09 Health Education Welfare Usa Tyrosine tranquilizing compositions and methods of treatment

Also Published As

Publication number Publication date
DE2821236A1 (de) 1978-11-30
FR2390955B1 (US20080094685A1-20080424-C00004.png) 1980-07-04
FR2390955A1 (fr) 1978-12-15

Similar Documents

Publication Publication Date Title
Stuart et al. WHO model formulary 2008
Tennant Jr et al. Narcotic maintenance for chronic pain: medical and legal guidelines
US5965571A (en) Cholinesterase inhibitors for treatment of Parkinson's disease
US4117161A (en) Method of pharmacologically treating drug addiction with alpha-methyl-para-tyrosine
US4165382A (en) Method of pharmacologically treating schizophrenia with alpha-methyl-para-tyrosine
Moore et al. Naloxone: underdosage after narcotic poisoning
HEISER et al. The reversal of anticholinergic drug-induced delirium and coma with physostigmine
Koren et al. Pediatric uses of opioids
MXPA03006411A (es) Empleo de flumazenilo en la elaboracion de un medicamento para el tratamiento de la dependencia de alcohol.
Shimp Safety issues in the pharmacologic management of chronic pain in the elderly
Jamal et al. Perioperative management of patients with myasthenia gravis: prevention, recognition, and treatment
Gallant et al. Withdrawal symptoms after abrupt cessation of antipsychotic compounds: Clinical confirmation in chronic schizophrenics
Offerhaus Drugs for the elderly
Whitledge et al. Diphenhydramine-induced antimuscarinic delirium treated with physostigmine and transdermal rivastigmine
GB1583625A (en) Compositions for pharmacologically treating drug addiction and schizophrenia
Sellers et al. Treatment of acetaminophen poisoning.
Shaw 8 Alcohol and the nervous system
Ketai Psychotropic drugs in the management of psychiatric emergencies
WO1999056747A1 (en) Compositions and methods for treating particular chemical addictions and mental illnesses
Lintzeris et al. Clinical guidelines: buprenorphine treatment of heroin dependence
Rooklin Theophylline: is it obsolete for asthma?
Traub et al. Acute neurotoxicology of drugs of abuse
Ellison et al. Emergency psychopharmacology: A review and update
Salzman et al. Geriatric psychopharmacology
Schonwald et al. Unsuspected quinine intoxication presenting as acute deafness and mutism

Legal Events

Date Code Title Description
PS Patent sealed
PCNP Patent ceased through non-payment of renewal fee